Summit Global Investments Makes New $107,000 Investment in Inogen, Inc. (NASDAQ:INGN)

Summit Global Investments acquired a new stake in shares of Inogen, Inc. (NASDAQ:INGN) during the fourth quarter, HoldingsChannel reports. The fund acquired 11,646 shares of the medical technology company’s stock, valued at approximately $107,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AlphaQuest LLC purchased a new stake in shares of Inogen during the fourth quarter valued at $43,000. Quarry LP purchased a new stake in Inogen in the 3rd quarter worth $59,000. Ieq Capital LLC acquired a new position in shares of Inogen during the 4th quarter worth about $94,000. Intech Investment Management LLC purchased a new position in shares of Inogen in the fourth quarter valued at approximately $94,000. Finally, Verition Fund Management LLC acquired a new stake in Inogen during the 3rd quarter worth $106,000. Institutional investors own 89.94% of the company’s stock.

Inogen Trading Down 1.6 %

Inogen stock opened at $7.25 on Wednesday. The firm has a market capitalization of $192.34 million, a P/E ratio of -3.22 and a beta of 1.15. The stock’s fifty day simple moving average is $9.62 and its 200-day simple moving average is $9.61. Inogen, Inc. has a twelve month low of $6.14 and a twelve month high of $13.33.

Wall Street Analysts Forecast Growth

INGN has been the subject of a number of recent research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a research note on Wednesday, February 26th. StockNews.com lowered Inogen from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th.

About Inogen

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.